6Reid AH, Attard G, Danila 13(2, et al. Significant and sustained antitumor activity in post-doeetaxel,castration-resistant prostate cancer with the CYP17 inhibitor abiraterone acetate[J]. J Clin Oneol,2010,28(9) : 1489-1495.
7Leeuwen PJ ,Bergh RC,Wolters T, et al. Critical assessment ofprebiopsy parameters for predicting prostate cancer metastasis and mortality[J]. Can J Urol, 2011 ,18(6) ..6018-6024.
8Liu X, Choi RY, Jawad SM, et al. Androgen - induced PSA expression requires not only activation of AR but also endogenous IGF-I or IGF-I/PI3K/Akt signaling in human prostate cancer epithelial cells[J]. Prostate, 2011,71 (7) : 766- 777.
9Giesing M, Suchy B, Driesel G, et al. Clinical utility of antioxidant gene expression levels in circulating cancer cell clusters for the detection of prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL and disease prognostication after radical prostatectorny[J]. BJU Int, 2010, 105(7) : 1000-1010.
10Thomas K J, Comadaby A J, Hammadch M, etal. Transurethral va- porization of the prostate : a promising new technique. Br J Urol 2007; 79(2) : 186 -189.
